in this study we assessed the viability of cultured human umbilical vein endothelial cells ( huve ) treated with bacterial lipopolysaccharide ( lps ) , recombinant human interleukin-1 ( rhil-1 ) , or recombinant human tumor necrosis factor-alpha ( rhtnf-alpha ) during inhibition of rna or protein synthesis .
C0035668
rna
C0597295
protein synthesis